← brief for 2026-10-15 · Slowing decline

CD38-targeted therapies in kidney disease: evidence maturity, disease-stage dependence, and biomarker-guided retreatment

Article No results yet Peer reviewed

Key takeaways

This review looks at drugs that target a protein called CD38. It covers how these drugs work in kidney disease and transplants. It summarizes what is already known from past studies. There are no new results from this paper itself.

Who did this work

Peidong Feng (Shaanxi University of Chinese Medicine) · Xiaoyong Yu (Shaanxi Provincial Hospital of Traditional Chinese Medicine)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-14
https://doi.org/10.3389/fmed.2026.1972506